The role of the mediators of inflammation in cancer development

Pathology Oncology Research : POR
José Veríssimo FernandesJosélio Maria Galvão de Araújo

Abstract

Epigenetic disorders such as point mutations in cellular tumor suppressor genes, DNA methylation and post-translational modifications are needed to transformation of normal cells into cancer cells. These events result in alterations in critical pathways responsible for maintaining the normal cellular homeostasis, triggering to an inflammatory response which can lead the development of cancer. The inflammatory response is a universal defense mechanism activated in response to an injury tissue, of any nature, that involves both innate and adaptive immune responses, through the collective action of a variety of soluble mediators. Many inflammatory signaling pathways are activated in several types of cancer, linking chronic inflammation to tumorigenesis process. Thus, Inflammatory responses play decisive roles at different stages of tumor development, including initiation, promotion, growth, invasion, and metastasis, affecting also the immune surveillance. Immune cells that infiltrate tumors engage in an extensive and dynamic crosstalk with cancer cells, and some of the molecular events that mediate this dialog have been revealed. A range of inflammation mediators, including cytokines, chemokines, free radicals, prostaglandins, gro...Continue Reading

References

Dec 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·K ShigeharaN Sato
Apr 3, 2003·Nature Reviews. Cancer·S Perwez HussainCurtis C Harris
Dec 18, 2003·Clinical and Experimental Immunology·F DriesslerA J Schottelius
Aug 3, 2004·Nature Reviews. Immunology·William C ParksYolanda S López-Boado
Sep 18, 2004·Cancer Letters·Shan ZhaAngelo M De Marzo
Nov 18, 2004·Immunological Reviews·Alain P Vicari, Giorgio Trinchieri
Mar 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rebecca L Elliott, Gerard C Blobe
Oct 6, 2005·Journal of Leukocyte Biology·Simone MocellinHoward A Young
Jul 17, 2007·Cancer Letters·Dayanidhi RamanAnn Richmond
Sep 26, 2007·International Journal of Cancer. Journal International Du Cancer·S Perwez Hussain, Curtis C Harris
Feb 10, 2009·The Journal of Biological Chemistry·F Xavier Gomis-Rüth
Mar 24, 2009·Annual Review of Immunology·Fabio MartinonJürg Tschopp
Apr 18, 2009·Microbes and Infection·Pierre Miossec
Aug 4, 2009·Journal of Molecular Cell Biology·Wanjun Chen, Joanne E Konkel
Sep 19, 2009·Nature Reviews. Genetics·Carlo M Croce
Aug 18, 2010·Current Medicinal Chemistry·S SrivastavaM J Robertson
Dec 8, 2010·Experimental Cell Research·Paola AllavenaAlberto Mantovani
May 3, 2011·Trends in Immunology·Andrew CopeClaudia Kemper
Jul 21, 2011·Pharmaceutical Research·Man Lung Yeung, Kuan-Teh Jeang
Dec 6, 2011·Immunologic Research·Takami SatoSenthamil R Selvan
Jan 10, 2012·Annual Review of Immunology·Ryan M O'ConnellDavid Baltimore
Jan 25, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·David J SharkeySarah A Robertson
Apr 25, 2012·World Journal of Gastrointestinal Surgery·Noemí Eiró, Francisco J Vizoso
Jun 1, 2012·The Cancer Journal·Aaron J SchetterCurtis C Harris
Jun 2, 2012·Cancer Treatment Reviews·Yuqi GuoZhan Zhang
Aug 21, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael J PattisonJ Simon C Arthur
Jan 15, 2013·Gynecologic Oncology·Tao TangKwong Wai Choy
Mar 6, 2013·The Journal of Pathology·John P WatersJohn R Bradley
Apr 5, 2013·Immunological Reviews·Esmerina TiliCarlo M Croce
Apr 5, 2013·Neoplasia : an International Journal for Oncology Research·Isaiah Gregory SchauerJinsong Liu
Aug 7, 2013·Molecular Cancer·Bastian Hoesel, Johannes A Schmid
Aug 13, 2013·Periodontology 2000·Georgina S Butler, Christopher M Overall
Aug 21, 2013·Trends in Immunology·Shin Foong NgiowMark J Smyth
Oct 15, 2013·Biochimica Et Biophysica Acta·Giuseppe PalmaClaudio Arra
Nov 13, 2013·The Journal of Clinical Investigation·C Andrew StewartGiorgio Trinchieri

❮ Previous
Next ❯

Citations

Nov 10, 2015·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Sirinart AromsereeTipaya Ekalaksananan
Oct 11, 2016·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Qi-Yong AiMichael K M Kam
Oct 6, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Abdullatif AzabAbed N Azab
Oct 25, 2016·Pathology Oncology Research : POR·Camila Cristina Guimarães NobreJosé Veríssimo Fernandes
Jun 11, 2016·Scientific Reports·Hsien-Feng LiaoJan-Gowth Chang
Oct 13, 2017·Nutrition Reviews·Jiali ZhengSusan E Steck
Nov 16, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Taiwo Betty AyelesoEmmanuel Mukwevho
Feb 7, 2018·Frontiers in Microbiology·Paula DíazAndrew F G Quest
Oct 24, 2017·Drug Delivery and Translational Research·Gil AizikGershon Golomb
Feb 20, 2019·Critical Reviews in Microbiology·Dan ZouYe Zhang
Aug 2, 2019·Biological & Pharmaceutical Bulletin·Wanida SukketsiriVaromyalin Tipmanee
Dec 17, 2015·World Journal of Gastroenterology : WJG·Manuel A ValenzuelaAndrew F G Quest
Sep 27, 2019·Frontiers in Immunology·Norahayu OthmanNadiah Abu
Apr 11, 2018·Oxidative Medicine and Cellular Longevity·Su Yeon LeeHo Sung Kang
May 12, 2020·The International Journal of Biological Markers·Li HuangShan Li
Aug 2, 2018·Clinical Science·Simona RonchettiCarlo Riccardi
Dec 27, 2017·European Journal of Clinical Nutrition·Juliana Almeida-de-SouzaPedro Moreira
Apr 14, 2018·Molecular Cancer·José M García-Heredia, Amancio Carnero
Apr 14, 2018·Journal of Immunology Research·Angélica Aponte-LópezSamira Muñoz-Cruz
Dec 9, 2017·Cancer Biology & Therapy·Himadri PatelNilesh Kumar Sharma
Nov 24, 2017·International Journal of Cancer. Journal International Du Cancer·Laure DossusSabina Rinaldi
Mar 16, 2019·Clinical Journal of the American Society of Nephrology : CJASN·Hong XuJuan-Jesus Carrero
Feb 23, 2019·International Journal of Cancer. Journal International Du Cancer·Anna LandbergKatja Fall
Jan 22, 2020·Journal of Clinical Laboratory Analysis·Cui-Ju MoZhao Cao
Oct 6, 2020·Journal of Immunology Research·Liliana R BalahuraMarieta Costache

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.